Supplementary Data from Changes in &lt;sup&gt;18&lt;/sup&gt;F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib